Safety and Performance of the Glyconics-SX System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT05198895

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Glyconics Ltd (from the registry)
Registry
  • NCT NCT05198895
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05198895. Allocation not applicable; no masking; primary purpose screening. Start 2022-08-01 (actual); primary completion 2022-10-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance of the Glyconics-SX System
Acronym
ANODE01
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Near-infrared (NIR)
Lead sponsor
Glyconics Ltd (class: industry)

Record details

Record id
cardio:ct-nct05198895
Content hash
4ad36e9af6629e02a0dc57ccc11ca10c0f18863d1600595f3b2fb620ec84a1c9